number
autoimmun
disord
affect
visual
function
larg
number
mechan
visual
pathway
could
potenti
target
autoimmun
attack
practic
retina
anterior
visual
pathway
optic
nerv
chiasm
recognis
affect
autoimmun
disord
multipl
sclerosi
one
commonest
caus
visual
loss
young
adult
frequenc
attack
optic
neuriti
condit
howev
basi
inflamm
multipl
sclerosi
confirm
autoimmun
lack
immun
process
known
highli
unusu
system
confin
cn
compart
role
adapt
immun
system
protect
organ
potenti
pathogen
either
elimin
isol
endogen
mechan
repair
promot
complex
disord
aris
adapt
immun
system
target
self
result
autoimmun
diseas
definit
autoimmun
system
proport
patient
affect
structur
relev
vision
twothird
human
brain
involv
process
visual
inform
eye
million
photoreceptor
fig
top
row
flow
inform
start
convers
photon
analogu
signal
retin
photoreceptor
convert
bipolar
cell
inner
nuclear
layer
fig
third
row
digit
signal
code
approxim
parallel
inform
stream
masland
repres
first
stage
parallel
analysi
mani
submod
visual
imag
contrast
motion
color
etc
size
retin
ganglion
cell
minusculeabout
volum
pyramid
cell
hippocampu
cortex
masland
retin
ganglion
cell
gener
visual
signal
along
hardwir
pathway
primari
visual
cortex
also
known
striat
cortex
balk
et
al
hardwir
pathway
anatom
basi
known
retinotop
pointtopoint
project
retina
henc
basi
visual
field
visual
cortex
tabl
holm
also
less
numer
nonetheless
signific
project
visual
cortic
area
involv
motion
process
tectum
involv
pupillari
reflex
therefor
ampl
substrat
differenti
effect
immun
process
parallel
pathway
process
within
singl
anatom
defin
structur
retina
optic
nerv
visual
cortex
select
deficit
color
vision
motion
percept
modal
potenti
manifest
autoimmunemedi
dysfunct
detail
human
retina
give
rise
retin
ganglion
cell
axon
enter
masland
permiss
macmillan
publish
natur
neurosci
petzold
et
al
optic
nerv
jona
et
al
axon
optic
nerv
partial
decuss
project
contralater
chiasm
retin
ganglion
cell
firstord
neuron
synaps
secondord
neuron
dorsal
later
genicul
nucleu
visual
process
continu
prasad
galetta
final
retinotop
project
secondord
neuron
result
retinotop
map
function
architectur
hubel
wiesel
visual
pathway
project
retina
shown
figur
primari
visual
cortex
earli
stage
cortic
visual
process
tong
beyond
multipl
extrastri
visual
area
involv
inform
process
sincich
horton
barton
optic
nerv
eye
development
part
central
nervou
system
cn
henc
share
mani
target
autoimmun
attack
rest
cn
inde
optic
nerv
consid
whitematt
tract
common
spinal
cord
cranial
nerv
time
seduct
beauti
fine
anatom
network
depend
visual
inform
process
involv
receptor
ion
channel
secondmesseng
cascad
sterl
receptor
voltageg
channel
extracellular
domain
also
potenti
target
autoimmun
guiliano
toraldo
di
francia
first
recogn
spatial
resolut
stimuli
reach
retina
better
dimens
photoreceptor
retina
permit
base
rayleigh
criterion
westheim
tabl
thu
even
function
visual
acuiti
basic
measur
clinic
practic
depend
upon
postreceptor
process
form
hyperacu
vernier
acuiti
reli
visual
cortic
function
full
anatom
extent
higher
visual
cortic
area
human
continu
unravel
aid
coregist
function
function
magnet
reson
imag
mri
magnetoelectroencephalographi
positron
emiss
tomographi
structur
imag
mri
studi
autoimmunemedi
loss
vision
refer
impair
disrupt
neuron
network
health
eye
brain
protect
system
hardwir
human
vision
first
second
thirdord
neuron
axon
hardwir
human
brain
transmit
analogu
digit
signal
hardwir
singl
pathway
enabl
retinotop
map
human
visual
cortex
littl
potenti
plastic
strict
definit
singl
pathway
model
balk
et
al
analogu
signal
analogu
signal
produc
photoreceptor
continu
signal
intens
vari
time
depend
lightinduc
metabol
opsin
therefor
variat
signal
carri
inform
light
enter
eye
fig
analogu
signal
photoreceptor
convert
retin
bipolar
cell
digit
signal
requir
higherlevel
visual
network
process
digit
signal
digit
signal
hardwir
visual
pathway
sampl
analogu
signal
fed
retin
bipolar
cell
photoreceptor
digit
signal
consist
seri
action
potenti
inform
digit
signal
encod
time
frequenc
action
potenti
retinotop
topograph
map
adjac
locat
retina
repres
adjac
neuron
dorsal
later
genicul
nucleu
minimum
resolv
detail
accord
gener
accept
physic
definit
diffract
limit
simplifi
limit
imag
resolut
relat
order
wavelength
wave
use
imag
exampl
rayleigh
criterion
wavelength
nm
circular
pupil
open
mm
put
relat
snellen
acuiti
uk
notat
us
notat
correspond
resolut
limit
rad
subject
optim
circumst
visual
acuiti
rad
might
achiev
essenti
visual
acuiti
depend
anatom
space
sensori
neuron
retina
wavelength
light
enter
eye
vernier
acuiti
human
visual
cortex
make
spatial
distinct
precis
time
better
visual
acuiti
socal
hyperacu
depend
sophist
inform
process
visual
human
brain
vernier
acuiti
repres
quintessenti
exampl
hyperacu
align
two
edg
line
judg
better
precis
predict
visual
acuiti
clinic
assess
exampl
normal
stereopsi
reli
hyperacu
inflammatori
respons
immun
system
autoimmun
visual
loss
follow
protect
mechan
structur
may
impair
see
section
blood
brain
barrier
blood
retina
barrier
brain
eye
common
immun
privileg
describ
relationship
organ
human
bodi
immun
system
thought
immun
privileg
necessari
protect
finetun
function
neuron
network
yet
fulli
understood
immun
privileg
develop
maintain
presenc
anatom
barrier
protect
immuneprivileg
organ
long
recogn
molecular
mechan
induct
apoptosi
invad
inflammatori
cell
discov
ferguson
griffith
bloodbrain
barrier
bbb
structur
compon
homoeostat
mechan
prevent
substanc
blood
stream
enter
extracellular
fluid
ecf
cn
fig
addit
bbb
also
bloodcerebrospin
fluid
csf
barrier
bcb
filter
permit
substanc
diffus
blood
csf
accord
molecular
size
import
distinguish
bbb
bcb
rigor
appli
literatur
petzold
integr
bbbbcb
function
assess
quantif
csf
serum
albumin
albumin
produc
intrathec
csf
albumin
must
deriv
blood
diffus
mening
intact
bbbbcb
allow
small
amount
albumin
diffus
csf
normal
quotient
csf
serum
albumin
calcul
confid
limit
ie
ratio
approxim
see
chapter
stangel
et
al
breakdown
bcb
lead
leakag
serum
albumin
local
csf
therefor
increas
quotient
indic
loss
integr
bbb
stangel
et
al
wide
rang
quotient
report
literatur
highlight
laboratori
need
establish
normal
rang
need
rigor
qualitycontrol
time
petzold
et
al
similar
bbb
bloodretina
barrier
brb
one
mechan
subserv
retin
homoeostasi
cunhavaz
et
al
inner
brb
regul
fluid
shift
molecular
exchang
retina
capillari
blood
extracellular
fluid
retina
cellular
level
inner
brb
consist
tight
junction
endothelium
cell
level
inner
limit
membran
likewis
outer
brb
consist
tight
junction
retin
pigment
epithelium
rpe
cell
abut
outer
aspect
bruch
membran
gener
accept
mainten
visual
function
critic
depend
intact
metabol
relationship
rpe
photoreceptor
fluorescein
angiographi
gold
standard
assess
brb
integr
fluorescein
leakag
indic
loss
integr
addit
role
retin
optic
coher
tomographi
oct
noninvas
techniqu
demonstr
fluid
accumul
retina
like
relat
brb
breakdown
gelfand
et
al
burggraaff
et
al
complement
system
bear
crucial
role
autoimmun
respons
minton
antibodi
bound
epitop
antigen
constitut
immun
complex
isotyp
antibodi
complement
activ
complement
bound
immun
complex
heyman
complement
activ
stimul
phagocytosi
directli
destroy
cell
exampl
system
lupu
erythematosu
sle
complement
activ
involv
autoantibodyiniti
tissu
damag
chen
et
al
similar
mechan
autoantibodi
neuromyel
optica
nmo
result
complementmedi
damag
astrocyt
cn
associ
loss
glial
fibrillari
acid
protein
stain
immunohistochemistri
bradley
et
al
bennett
et
al
saadoun
et
al
increas
csf
glial
fibrillari
acid
protein
level
major
specif
protein
antigen
astrocyt
consist
found
acut
attack
nmo
petzold
observ
led
term
autoimmun
astrocytopathi
lucchinetti
et
al
altern
term
autoimmun
channelopathi
suggest
pittock
lucchinetti
appli
disord
well
spectrum
neurolog
channelopathi
larg
none
yet
associ
visual
loss
vincent
et
al
kullmann
surpris
mani
immun
target
autoimmun
channelopathi
highli
express
optic
nerv
retina
visual
network
paroxysm
episod
visual
loss
observ
clinic
understood
exampl
case
nonembol
transient
monocular
blind
could
due
channelopathi
petzold
et
al
b
might
paroxysm
symptom
multipl
sclerosi
ms
includ
deterior
vision
rise
bodi
temperatur
uhthoff
phenomenon
petzold
et
al
potassium
channel
also
known
resid
astrocyt
one
recent
candid
possibl
autoimmun
channelopathi
affect
visual
system
ms
srivastava
et
al
potassium
channel
highli
express
optic
nerv
cell
retina
howev
yet
possibl
replic
find
antibodi
ms
brickshawana
et
al
antibodi
describ
gold
standard
becom
detect
antibodi
bind
protein
natur
environ
surfac
human
cell
issu
discuss
detail
chapter
health
immun
system
come
contact
mani
intracellular
neuron
compon
due
immuneprivileg
natur
mother
organ
howev
patholog
process
caus
releas
compon
neuron
within
visual
system
could
give
rise
immun
reaction
self
antigen
new
patholog
event
relaps
increas
likelihood
reactiv
secondari
autoimmun
reaction
hand
difficult
know
whether
antibodi
epiphenomena
direct
pathogen
relev
petzold
diagnost
workup
guid
patient
histori
clinic
assess
fig
tabl
list
warn
sign
trigger
escal
diagnost
procedur
differenti
spectrum
domin
msassoci
optic
neuriti
mson
red
flag
alert
clinician
potenti
altern
diagnos
red
flag
refer
either
symptom
sign
present
diseas
cours
therefor
patient
need
follow
least
optic
neuriti
common
present
symptom
patient
ms
petzold
et
al
preval
ms
vari
consider
planet
fig
distinguish
optic
neuriti
ms
form
optic
neuriti
use
abbrevi
mson
petzold
et
al
histor
number
report
optic
neuriti
predat
semin
paper
ms
charcot
august
dest
month
onset
fig
diagnost
workup
patient
present
autoimmun
visual
loss
clinic
decis
whether
patient
requir
investig
depend
key
point
histori
clinic
examin
approxim
cost
us
dollar
relat
escal
investig
given
gener
guidanc
fee
vari
substanti
institut
clinic
decis
tree
emphas
pertin
question
point
horizont
ye
close
line
vertic
answer
dot
line
cn
central
nervou
system
oct
optic
coher
toographi
mri
magnet
reson
imag
mmo
microcyst
macular
edema
inl
inner
nuclear
layer
ms
multipl
sclerosi
optic
neuriti
vep
visual
evok
potenti
erg
electroretinographi
modifi
petzold
et
al
frequent
cite
case
firth
typic
clinic
present
periorbit
pain
occur
exacerb
eye
movement
preced
visual
loss
posit
visual
symptom
may
present
onset
neg
visual
symptom
reach
nadir
within
week
recov
substanti
month
residu
symptom
includ
dyschromatopsia
impair
contrast
sensit
uhthoff
phenomenon
pulfrich
phenomenon
visual
fade
glare
disabl
tabl
petzold
et
al
clinic
differenti
diagnosi
larg
guid
analysi
autoantibodi
particularli
presenc
red
flag
indic
atyp
present
diseas
cours
tabl
consist
find
ms
experiment
model
ms
number
autoantibodi
myelin
protein
report
mson
petzold
myelin
oligodendrocyt
glycoprotein
mog
myelin
basic
protein
myelinassoci
oligodendrocyt
basic
protein
evid
suggest
associ
paraneoplast
antibodi
mson
stich
et
al
howev
common
limit
studi
assumpt
optic
neuriti
due
ms
clinic
data
miss
petzold
et
al
data
regard
antibodi
emerg
particularli
antibodi
mog
relaps
bilater
simultan
optic
neuriti
posit
may
chang
eug
ene
devic
publish
clinic
cours
postmortem
examin
woman
present
bilater
visual
loss
week
suffer
intestin
problem
sleepless
weak
headach
optic
disc
swell
sever
retin
hemorrhag
also
present
die
day
later
clinic
diagnosi
acut
myeliti
bilater
optic
neuriti
confirm
patholog
histor
earlier
descript
associ
visual
loss
spinal
cord
inflamm
see
semin
discoveri
diagnost
autoantibodi
research
autoimmun
visual
loss
nmo
made
progress
lennon
et
al
topic
cover
gener
chapter
clinic
differenti
diagnosi
straightforward
patient
present
simultan
optic
neuriti
myeliti
case
alway
posit
antibodi
wingerchuk
et
al
difficult
patient
present
acut
unilater
optic
neuriti
isol
nmoon
petzold
et
al
nmo
visual
loss
tend
sever
poorer
outcom
compar
mson
petzold
plant
distinct
may
howev
also
reflect
need
adequ
treatment
nmoon
mson
outcom
tend
favor
even
absenc
treatment
nmoon
visual
field
abnorm
less
diffus
mson
wors
foveal
threshold
nakajima
et
al
merl
et
al
patient
nmoon
suffer
total
visual
loss
compar
mson
merl
et
al
altitudin
visual
field
defect
also
observ
anatom
suggest
focal
patholog
dorsal
ventral
optic
nerv
nakajima
et
al
merl
et
al
optic
nerv
imag
nmoon
demonstr
elong
lesion
posterior
nerv
frequent
involv
chiasm
contralater
optic
nerv
compar
mson
khanna
et
al
storoni
et
al
discoveri
nmo
igg
lennon
et
al
later
describ
specif
autoantibodi
water
channel
lennon
et
al
highli
specif
diagnost
test
nmoon
becam
avail
current
gold
standard
cellbas
assay
sensit
water
et
al
follow
complementmedi
damag
astrocyt
glial
fibrillari
acid
protein
specif
astrocyt
protein
releas
extracellular
fluid
csf
provid
addit
test
may
help
case
petzold
characterist
astrocyt
damag
nmo
lead
patholog
motiv
term
autoimmun
astrocytopathi
lucchinetti
et
al
definit
term
use
visual
symptom
typic
observ
follow
unilater
optic
neuriti
contrast
sensit
measur
visual
function
relev
patient
visual
qualiti
life
contrast
sensit
might
reduc
whilst
highcontrast
snellen
visual
acuiti
normal
contrast
sensit
defin
abil
discern
lumin
differ
level
static
imag
optim
level
contrast
sensit
reach
within
year
age
declin
age
diseas
strongli
influenc
refract
higher
spatial
frequenc
smaller
spatial
element
therefor
reliabl
clinic
assess
contrast
sensit
requir
bestcorrect
visual
acuiti
use
dyschromatopsia
assess
color
vision
provid
even
finer
measur
visual
function
contrast
sensit
color
defin
hue
satur
bright
quantifi
follow
optic
neuriti
acquir
deficit
color
percept
patient
frequent
report
color
appear
wash
affect
eye
due
loss
satur
glare
defin
difficulti
see
presenc
bright
light
subject
experi
glare
disabl
exampl
bright
head
light
back
mirror
car
night
follow
optic
neuriti
patient
also
describ
glare
disabl
discomfort
photosensit
daylight
artifici
light
pulfrich
phenomenon
defin
carl
pulfrich
stereoeffect
petzold
pitz
patient
difficulti
judg
movement
depth
readili
correct
tint
spectacl
darkershad
glass
front
better
eye
uhthoff
phenomenon
transient
worsen
function
vision
chang
bodi
temperatur
may
report
patient
follow
warm
showerbath
sport
stress
hot
meal
higher
environment
temperatur
function
restor
normal
bodi
temperatur
visual
fade
physiolog
phenomenon
troxler
effect
occur
prolong
visual
fixat
lead
fade
disappear
small
object
visual
field
phenomenon
enhanc
follow
optic
neuriti
time
write
increas
proport
patient
report
problem
digit
screen
comput
smartphon
tablet
exampl
prolong
visual
fixat
excel
sheet
may
lead
disappear
line
smaller
print
central
visual
field
phenomenon
transient
look
away
back
restor
visual
function
distinguish
fade
vision
brightlight
condit
relat
steadi
fixat
see
petzold
et
al
patient
defin
clinic
radiolog
nmo
antibodi
use
current
avail
techniqu
patient
mog
antibodi
prove
help
defin
nonm
form
nmo
spectrum
disord
includ
case
optic
neuriti
kitley
et
al
sato
et
al
confus
field
stem
partli
use
unsuit
secondari
antibodi
assay
specif
igg
antibodi
ms
patient
rare
posit
water
et
al
mog
antibodi
thu
emerg
new
form
autoimmun
whitematt
diseas
particularli
common
sever
relaps
optic
neuriti
patient
crion
describ
diagnost
criteria
includ
depend
immunosuppress
make
autoimmun
pathogenesi
like
petzold
plant
geograph
therefor
ethnic
distribut
probabl
differ
ms
fig
data
need
interpret
caution
owe
lack
populationbas
epidemiolog
studi
histori
optic
neuriti
least
one
relaps
clinic
object
evid
loss
visual
function
laboratori
nmo
igg
seroneg
imag
contrast
enhanc
acut
inflam
optic
nerv
treatment
respons
immunosuppress
treatment
relaps
withdraw
dose
reduct
immunosuppress
treatment
typic
patient
experi
relaps
cessat
immunosuppress
reduct
usual
corticosteroid
dosag
certain
critic
individu
variabl
level
petzold
plant
b
recommend
test
autoantibodi
patient
suspect
crion
rule
nmo
petzold
et
al
likewis
test
mog
antibodi
could
help
valid
assay
becom
avail
wide
patient
crion
requir
longterm
immunosuppress
also
advis
hyperacut
treatment
acut
relaps
optic
neuriti
may
occur
despit
system
immunosuppress
particularli
dose
taper
establish
minimum
requir
plant
et
al
visual
loss
describ
patient
igg
biotti
et
al
patient
suffer
transient
sensori
symptom
follow
febril
infect
optic
nerv
second
highest
densiti
gangliosid
express
cn
therefor
may
suscept
transient
antibodymedi
conduct
block
similar
occur
millerfish
syndrom
affect
ocular
motor
nerv
myelin
protein
includ
mog
transmembran
protein
expos
myelin
sheath
cn
mog
wellrecogn
antigen
target
human
cn
demyelin
experiment
form
optic
neuriti
induc
activ
immun
mog
epitop
weissert
et
al
chapter
review
spectrum
human
diseas
associ
mog
autoantibodi
reveal
heterogen
clinic
group
reindl
et
al
discuss
mson
limit
previou
studi
possibl
associ
mog
autoantibodi
optic
neuriti
need
detail
data
relaps
steroid
depend
bilater
simultaneoussequenti
onset
petzold
et
al
presenc
reliabl
assay
high
specif
serum
mog
igg
antibodi
demonstr
patient
relaps
optic
neuriti
number
group
reindl
et
al
kitley
et
al
martinezhernandez
et
al
major
neg
antibodi
test
use
cellbas
assay
measur
mog
antibodi
reindl
et
al
kitley
et
al
coexist
mog
autoantibodi
glycin
receptor
autoantibodi
describ
patient
martinezhernandez
et
al
emerg
clinic
phenotyp
relaps
potenti
steroiddepend
frequent
bilater
simultan
sequenti
optic
neuriti
may
isol
associ
transvers
myeliti
import
test
larg
cohort
phenotyp
welldefin
patient
rion
crion
petzold
et
al
presenc
mog
autoantibodi
studi
perform
improv
cellbas
assay
use
iggspecif
secondari
antibodi
rather
commonli
use
antiigg
heavi
light
chain
bind
class
igg
includ
igm
water
et
al
figur
show
mri
oct
one
author
patient
mog
antibodi
relaps
optic
neuriti
serum
antibodi
detect
patient
experienc
bilater
simultan
optic
neuriti
child
associ
less
threeseg
myelopathi
relaps
sequenti
bilater
optic
neuriti
develop
adulthood
loss
vision
right
eye
preced
sever
pain
eye
movement
pain
visual
analogu
scale
va
follow
pain
eye
movement
visual
loss
left
eye
within
week
activ
inflamm
optic
nerv
document
mri
elsewher
fig
patient
refer
center
bilater
pale
optic
disc
note
followup
anoth
episod
acut
optic
neuriti
develop
right
eye
preced
pain
eye
movement
document
mri
fig
immunosuppress
treatment
initi
situat
stabil
followup
sever
bilater
optic
atrophi
averag
peripapillari
retin
nerv
fiber
layer
thick
mm
right
mm
left
fig
lhon
name
impli
genet
diseas
riordaneva
et
al
typic
young
male
present
painless
loss
vision
famili
histori
visual
loss
male
cousin
matern
side
uncommon
interestingli
suggest
clinic
featur
lhon
explain
genet
smith
et
al
smith
et
al
found
tubulin
autoantibodi
patient
lhon
antibodi
report
optic
neuriti
ms
rang
neurolog
disord
howev
tubulin
ubiquit
intracellular
protein
possibl
antibodi
repres
respons
tissu
damag
gener
epiphenomen
sarcoidosi
diseas
unknown
etiolog
question
prioriti
descript
resolv
scad
iron
one
contend
first
descript
jonathan
hutchinson
hutchinson
surgeon
moorfield
eye
hospit
describ
associ
visual
loss
report
visual
loss
sarcoidosi
first
appear
long
schaumann
recogn
system
natur
sarcoidosi
levitt
cn
involv
case
optic
nerv
involv
depend
patient
ethnic
background
kidd
beynon
scott
et
al
typic
duralbas
granulomat
inflamm
lesser
degre
parenchym
noncas
granuloma
kidd
beynon
loss
vision
due
uveiti
granuloma
orbit
visual
pathway
petzold
et
al
patient
sarcoidosisassoci
optic
neuropathi
may
experi
uhthoff
phenomenon
symptom
usual
associ
demyelin
haupert
newman
sarcoidosi
may
also
mimic
symptom
cancerassoci
retinopathi
koesting
et
al
gold
standard
diagnosi
tissu
biopsi
alway
possibl
neuroophthalm
case
due
site
involv
patient
african
afrocaribbean
heritag
greater
risk
sarcoidosi
optic
neuriti
pokroy
et
al
rare
differenti
diagnosi
blau
syndrom
hereditari
granulomat
diseas
caus
mutat
gene
caso
et
al
blau
syndrom
earli
eye
involv
iriti
uveiti
aggress
risk
blind
treat
appropri
condit
interest
carri
featur
inflammatori
autoimmun
condit
caso
et
al
paradox
observ
support
possibl
autoimmun
etiolog
sarcoidosi
rare
coexist
common
variabl
immunodefici
dziadzio
et
al
although
characterist
skin
lesion
sle
alreadi
document
physician
rogeriu
keil
moric
kaposi
born
cohen
recogn
system
natur
diseas
kaposi
sle
variabl
clinic
present
diseas
cours
prognosi
cn
involv
may
indic
poorer
prognosi
may
therefor
lead
aggress
treatment
bertsia
et
al
mri
show
activ
sle
lesion
cn
system
laboratori
marker
sle
includ
anemia
thrombocytopenia
leukopenia
increas
serum
cretatinin
hyperferritinemia
rang
posit
antibodi
dsdna
phospholipid
rnp
ro
ssa
lassb
reduc
serum
complement
concentr
bertsia
et
al
brey
et
al
visual
impair
sle
caus
inflamm
cn
vascular
complic
typic
branch
retin
arteri
occlus
brandt
et
al
brown
et
al
remain
debat
whether
sle
caus
autoimmun
optic
neuriti
eleven
case
report
literatur
cinefro
frenkel
deutsch
corwin
eckstein
et
al
frigui
et
al
mild
optic
disc
swell
report
patient
treat
corticosteroid
visual
recoveri
moder
complet
frigui
et
al
focal
vascular
occlus
event
involv
ciliari
vasculatur
suggest
altern
differenti
diagnosi
frigui
et
al
optic
chiasmiti
associ
sle
also
report
frohman
et
al
howev
one
studi
frigui
et
al
predat
discoveri
autoantibodi
patient
frigui
et
al
appear
test
import
overlap
sle
nmo
estim
pittock
et
al
patient
sle
optic
neuriti
transvers
myeliti
test
autoantibodi
petzold
et
al
possibl
nonvascularbas
damag
optic
nerv
sle
may
caus
overlap
autoimmun
antiphospholipid
autoantibodi
associ
increas
risk
ischem
stroke
may
requir
treatment
anticoagul
brey
et
al
one
studi
describ
transient
monocular
blind
sle
antiphospholipid
autoantibodi
donder
et
al
show
frequent
attack
patient
experienc
attack
typic
last
minut
one
patient
last
hour
pattern
visual
field
defect
heterogen
perceiv
black
blur
gray
spot
donder
et
al
common
nonembol
transient
monocular
blind
petzold
et
al
differenti
diagnosi
transient
monocular
blind
sle
includ
secondari
retin
vasospasm
tabl
petzold
et
al
emboli
giorgi
et
al
sle
also
present
pseudotumor
cerebri
affect
visual
function
result
attend
papilledema
deschler
et
al
associ
sle
retinopathi
also
describ
klinkhoff
et
al
consensu
classif
vasculit
disord
author
separ
vascul
relat
infect
tabl
noninfecti
primari
secondari
vascul
tabl
latter
group
domin
rheumat
diseas
former
embrac
larg
number
condit
case
autoimmun
contribut
least
partli
patholog
process
mani
condit
respond
well
corticosteroid
vascul
caus
local
ischemia
part
visual
system
retina
smallvessel
vascul
caus
branch
retin
arteri
occlus
present
acut
local
ischem
area
later
stage
atrophi
sector
central
retin
arteri
occlus
caus
ischemia
whole
retina
except
spare
presenc
ciliari
arteri
gener
ischem
tissu
damag
extens
largevessel
vascul
larg
bodi
literatur
discuss
possibl
relationship
vaccin
autoimmun
diseas
case
optic
neuriti
good
evid
least
tempor
relationship
vaccin
subsequ
visual
loss
mostli
follow
influenza
also
mani
vaccin
children
postvaccin
optic
neuriti
may
achiron
petzold
et
al
featur
acut
demyelin
encephalomyel
recoveri
vision
typic
good
fujii
et
al
numer
report
optic
neuriti
follow
almost
type
infect
tabl
challeng
establish
causal
link
interpret
data
need
take
epidemiolog
relat
pathogen
account
herpesvirus
particular
high
preval
patient
retrobulbar
optic
neuriti
papil
neuroretin
vascul
may
coexist
occur
isol
vishwanath
et
al
accept
like
report
bia
first
present
seem
case
isol
unilater
bilater
optic
neuriti
solid
evid
caus
case
postinfecti
vascul
earli
treatment
corticosteroid
might
improv
outcom
although
situat
one
author
case
bilater
optic
neuriti
follow
gener
infect
unknown
etiolog
poor
outcom
fig
percept
light
eye
despit
acut
treatment
highdos
corticosteroid
prolong
oral
taper
vogtkoyanagiharada
syndrom
autoimmun
diseas
affect
multipl
system
pan
hiros
patholog
eye
frequent
involv
uveiti
optic
neuriti
vogtkoyanagiharada
syndrom
rare
organ
involv
inner
ear
tinnitu
hear
loss
skin
patchi
depigment
vitiligo
hair
patchi
loss
mening
headach
photophobia
frequent
present
symptom
rao
et
al
autoantibodi
found
cell
outer
segment
photoreceptor
rang
tissu
antigen
review
braithwait
et
al
consist
data
autoantibodi
direct
melanocyt
immunosuppress
treatment
may
requir
greco
et
al
oct
help
distinguish
serou
retin
detach
type
optic
disc
swell
type
vogtkoyanagiharada
diseas
addit
enhanc
depth
imag
oct
use
tool
assess
thicken
choroid
frequent
find
vogtkoyanagiharada
syndrom
fig
nakayama
et
al
follow
treatment
thin
choroid
nakayama
et
al
petzold
et
al
extraintestin
manifest
inflammatori
bowel
diseas
includ
optic
neuriti
report
patient
suffer
crohn
diseas
gupta
et
al
feleki
et
al
occasion
diagnosi
optic
perineur
made
mcclelland
et
al
tung
et
al
optic
neuriti
may
complic
inflammatori
bowel
diseas
treatment
sever
case
report
associ
treatment
tumor
necrosi
factor
inhibitor
chan
castellano
tristano
may
requir
discontinu
treatment
andor
chang
differ
immunosuppress
drug
feleki
et
al
patient
improv
corticosteroid
treatment
tran
et
al
han
et
al
feleki
et
al
ouakaakcha
et
al
barabino
et
al
figur
show
person
case
suffer
crohn
diseas
episod
painless
isol
optic
neuriti
left
eye
notabl
treat
tumor
necrosi
factor
inhibitor
visual
evok
potenti
prolong
left
ms
normal
right
ms
patient
respond
corticosteroid
left
disabl
central
scotoma
due
local
atrophi
papillomacular
bundl
left
eye
nonparaneoplast
autoimmun
retinopathi
common
paraneoplast
retinopathi
discuss
first
braithwait
et
al
grang
et
al
diagnost
workup
autoimmun
retinopathi
includ
oct
autofluoresc
electrodiagnost
test
fig
common
find
hyperautofluoresc
perimacular
ring
associ
oct
evid
loss
outer
retin
structur
innerout
segment
layer
presenc
microcyst
chang
particularli
inner
nuclear
layer
also
report
grang
et
al
presenc
autoimmun
retinopathi
absenc
cancer
describ
patient
mizen
et
al
clinic
electrophysiolog
featur
typic
cancerassoci
retinopathi
evid
cancer
year
followup
respect
visual
field
loss
progress
year
also
strong
famili
histori
autoimmun
diseas
second
patient
eventu
diagnos
common
variabl
immunodefici
typic
stain
inner
plexiform
layer
serum
patient
shown
figur
b
absenc
inner
plexiform
layer
stain
control
serum
fig
clinic
patient
present
asymmetr
clinic
featur
electrophysiolog
evid
bilater
patholog
one
second
eye
becam
symptomat
followup
particularli
first
patient
immunohistochem
evid
ipltarget
autoimmun
correl
well
electrophysiolog
evid
bipolar
cell
dysfunct
see
reduc
bwave
fig
combin
progress
visual
loss
scotomata
visual
field
deficit
electrophysiolog
abnorm
circul
retin
antibodi
case
strongli
support
diagnosi
autoimmun
retinopathi
braithwait
et
al
grang
et
al
need
develop
valid
standard
test
autoantibodi
poor
interlaboratori
agreement
braithwait
et
al
grang
et
al
low
avail
around
world
variou
center
autoimmun
form
retin
autoantibodi
report
antibodi
aenolas
cellspecif
antigen
arrestin
carbon
anhydras
heat
shock
neurofila
protein
photoreceptor
cellspecif
nuclear
receptor
recoverin
transducinb
transient
receptor
potenti
cation
channel
subfamili
member
braithwait
et
al
grang
et
al
accept
standard
detect
antibodi
case
diseasespecif
treatment
nonparaneoplast
autoimmun
retinopathi
remain
essenti
empir
corticosteroid
intraven
immunoglobulin
plasmapheresi
mycophenol
mofetil
azathioprin
cyclosporin
rituximab
tri
vari
success
braithwait
et
al
grang
et
al
difficulti
futur
trial
small
number
patient
diseas
cours
stabil
time
pattern
visual
field
loss
variabl
central
paracentr
scotoma
peripher
constrict
common
petzold
plant
progress
visual
field
loss
combin
photopsia
nyctalopia
suggest
melanomaassoci
retinopathi
cancerassoci
retinopathi
rahimi
sarraf
cancerassoci
retinopathi
common
melanomaassoci
retinopathi
grang
et
al
paraneoplastictrigg
autoimmun
visual
loss
associ
antibodi
major
paraneoplast
antigen
includ
hu
yo
ri
tr
voltageg
calcium
channel
associ
relev
tumor
batal
dalmau
braithwait
et
al
electrodiagnost
test
help
fig
data
fig
light
microscop
photograph
retin
immunocytochemistri
perform
use
serum
patient
patient
b
normal
control
subject
c
tissu
stain
immunoperoxidas
follow
counterstain
methyl
green
inner
retina
top
photograph
photoreceptor
layer
pr
bottom
patient
sera
specif
label
inner
plexiform
layer
ipl
arrow
reproduc
permiss
mizen
et
al
petzold
et
al
trial
treatment
target
primari
tumor
plasma
exchang
may
also
consid
case
liu
et
al
sawyer
et
al
first
describ
cancerassoci
retinopathi
patient
bronchial
carcinoma
cancerassoci
retinopathi
subsequ
also
found
malign
breast
cervix
endometrium
ovari
prostat
bladder
thymu
thyroid
pancrea
colon
hematolog
malign
rahimi
sarraf
central
paracentr
scotoma
note
case
rapid
progress
visual
field
loss
typic
painless
ohguro
et
al
bilater
visual
loss
common
mizen
et
al
present
follow
unilater
asymmetr
visual
field
loss
chan
nonparaneoplast
neurolog
diseas
unlik
paraneoplast
antibodi
caus
visual
symptom
complementmedi
autoimmun
possibl
mechan
patient
visual
field
loss
typic
persist
autoantibodi
bind
retin
ganglion
cell
antibodi
recoverin
enolas
probabl
establish
braithwait
et
al
howev
possibl
subgroup
domin
outer
retin
patholog
cone
dysfunct
lead
photosensit
reduc
color
vision
central
scotomata
rod
dysfunct
caus
nyctalopia
prolong
dark
adapt
peripher
andor
ring
scotomata
goldstein
et
al
vaphiad
et
al
ripp
et
al
first
describ
associ
night
blind
nyctalopia
photopsia
man
melanoma
author
hypothes
toxic
properti
chosen
chemotherapi
vincristin
caus
ripp
et
al
gener
gass
credit
recogn
melanomaassoci
retinopathi
syndrom
gass
berson
lessel
typic
clinic
present
night
blind
frequent
associ
photopsia
shimmer
border
braithwait
et
al
contrast
cancerassoci
retinopathi
slow
progress
make
differenti
diagnosi
retin
disord
acut
zonal
occult
outer
retinopathi
azoor
challeng
howev
less
like
discret
scotomata
melanomaassoci
retinopathi
found
azoor
perimetri
unreli
melanomaassoci
retinopathi
constant
photopsia
occur
throughout
visual
field
mimic
target
autom
perimetri
azoor
photopsia
tend
restrict
scotomata
autoantibodi
found
melanomaassoci
retinopathi
stain
bipolar
layer
retina
weinstein
et
al
keltner
et
al
nyctalopia
frequent
clinic
find
melanomaassoci
retinopathi
would
surpris
autoantibodi
found
melanomaassoci
retinopathi
would
specif
target
bipolar
cell
specif
rod
function
fig
third
row
howev
time
write
valid
diagnost
antibodi
braithwait
et
al
suggest
candid
autoantibodi
target
two
isoform
fructos
biphosph
aldolas
aldoals
c
lu
et
al
histor
associ
glycolyt
enzym
autoimmun
cn
uncommon
juri
still
whether
patholog
relev
epiphenomen
petzold
machem
first
describ
paraneoplast
melanocyt
prolifer
patient
suffer
rapid
progress
visual
loss
melanocyt
prolifer
caus
destruct
uveal
tissu
retina
rpe
fundoscopi
demonstr
pigment
pale
melanocyt
tumor
oct
show
subretin
fluid
hyperreflect
spot
irregular
thicken
rpe
level
rpe
en
face
oct
show
dark
spot
correspond
hyperfluoresc
spot
bluelight
autofluoresc
jansen
et
al
visual
symptom
preced
discoveri
primari
tumor
mile
et
al
suggest
presenc
antibodi
induc
melanocyt
prolifer
syndrom
also
call
bilater
diffus
uveal
melanocyt
prolifer
respond
plasma
exchang
mile
et
al
jansen
et
al
caus
unknown
import
differenti
diagnosi
particular
nonparaneoplast
autoimmun
retinopathi
azoor
grang
et
al
mrejen
et
al
typic
clinic
present
azoor
uniocular
circumscrib
visual
field
defect
posit
symptom
predominantli
outer
border
defect
gass
et
al
border
region
appear
brighter
blue
autofluoresc
electrodiagnost
test
oct
support
diagnosi
confirm
outer
retin
photoreceptor
dysfunct
consider
proport
patient
azoor
concomit
autoimmun
diseas
gass
et
al
heckenl
ferreyra
ongo
research
identifi
candid
retin
autoantibodi
futur
clinic
laboratori
valid
studi
evid
base
treatment
although
corticosteroid
sometim
prescrib
acut
phase
local
form
retin
name
accord
part
retina
affectedif
peripapillari
idiopath
big
blind
spot
syndrom
paramacular
macular
neuroretin
condit
relat
azoor
uncertain
oct
confirm
similar
locat
patholog
idiopath
big
blind
spot
syndrom
tend
uniocular
macular
neuroretin
tend
binocular
posit
symptom
local
scotomata
characterist
group
condit
petzold
et
al
chapter
review
diagnosi
autoimmunerel
visual
loss
broader
basi
usual
cover
clinic
review
design
highlight
import
consid
autoimmun
visual
loss
consequ
system
diseas
howev
evid
primari
autoimmun
target
visual
system
miss
mani
condit
differenti
diagnos
mostli
includ
occlus
vascular
patholog
autoimmun
epiphenomena
follow
tissu
damag
autoinflamm
relat
hereditari
diseas
cancer
nonspecif
system
inflamm
respons
whole
rang
infecti
diseas
vaccin
notabl
exampl
specif
autoimmun
target
nonmyelin
myelin
part
visual
system
one
diseas
nmo
astrocyt
nonmyelin
axon
neuron
cell
bodi
retina
succumb
autoimmun
diseas
proxim
myelin
partner
autoantibodi
distinct
although
avail
valid
test
marker
immunotherapi
respons
diseas
identifi
potenti
relev
refer
full
list
request
author
aim
reach
balanc
select
refer
origin
clinic
descript
landmark
autoimmun
discoveri
within
space
limit
chapter
